Earnings Feed
Start Free
Home/Filings/4/0001077183-25-000042
4//SEC Filing

Harris Melody 4

Accession 0001077183-25-000042

CIK 0001077183other
View on SEC.govCompany Profile

Filed

Feb 24, 7:00 PM ET

Accepted

Feb 25, 4:40 PM ET

Size

29.3 KB

Accession

0001077183-25-000042

Insider Transaction Report

Form 4
Period: 2025-02-21
NEOGENOMICS INCNEO
Harris Melody
Chf Ops Off, Pres, Informatics
Transactions
  • Tax Payment

    Common Stock

    2025-02-23−2,056→ 109,755 total
  • Exercise/Conversion

    Restricted Stock Unit

    2025-02-23−8,443→ 16,886 total
    Exercise: $0.00→ Common Stock (8,443 underlying)
  • Exercise/Conversion

    Common Stock

    2025-02-23+8,443→ 111,811 total
  • Award

    Stock Option (Right to Buy)

    2025-02-21+143,266→ 143,266 total
    Exercise: $13.05Exp: 2035-02-21→ Common Stock (143,266 underlying)
  • Award

    Restricted Stock Unit

    2025-02-21+84,317→ 84,317 total
    Exercise: $0.00→ Common Stock (84,317 underlying)
Holdings

  • Stock Option (Right to Buy)

    Exercise: $19.65Exp: 2030-05-11→ Common Stock (39,683 underlying)
    39,683

  • Performance Stock Unit

    Exercise: $0.00From: 2026-05-11→ Common Stock (21,204 underlying)
    21,204

  • Stock Option (Right to Buy)

    Exercise: $16.45Exp: 2034-02-23→ Common Stock (42,344 underlying)
    42,344

  • Performance Stock Unit

    Exercise: $0.00From: 2027-05-02→ Common Stock (11,939 underlying)
    11,939

  • Restricted Stock Unit

    Exercise: $0.00→ Common Stock (11,939 underlying)
    11,939

  • Stock Option (Right to Buy)

    Exercise: $9.24Exp: 2030-01-01→ Common Stock (201,613 underlying)
    201,613

  • Restricted Stock Unit

    Exercise: $0.00→ Common Stock (14,136 underlying)
    14,136

  • Performance Stock Unit

    Exercise: $0.00From: 2027-02-23→ Common Stock (25,330 underlying)
    25,330

  • Stock Option (Right to Buy)

    Exercise: $13.96Exp: 2034-05-02→ Common Stock (19,984 underlying)
    19,984

  • Restricted Stock Unit

    Exercise: $0.00From: 2026-01-13→ Common Stock (59,382 underlying)
    59,382
Footnotes (17)
  • [F1]Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.
  • [F10]On May 11, 2023, Ms. Harris was granted 39,683 stock options. These options vest ratably over the first three anniversary dates of the grant date.
  • [F11]On May 11, 2023, Ms. Harris was granted 21,204 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
  • [F12]On May 11, 2023, Ms. Harris was granted 21,204 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to theperformance criteria is31,806. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stockover the 20-day trailing trading period at theapplicable measurement dates, subject to continued service with the Company.
  • [F13]On February 23, 2024, Ms. Harris was granted 42,344 stock options. These options vest ratably over the first three anniversary dates of the grant date
  • [F14]On February 23, 2024, Ms. Harris was granted 25,330 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant tothe performance criteria is37,996. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company'scommon stock over the 20-day trailing trading period atthe applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based onthe achievement of certain revenue growth goals based on the achievement of thecumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.
  • [F15]On May 2, 2024, Ms. Harris was granted 19,984 stock options. These options vest ratably over the first three anniversary dates of the grant date.
  • [F16]On May 2, 2024, Ms. Harris was granted 11,939 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to theperformance criteria is17,909. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company'scommon stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based onthe achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.
  • [F17]On May 2, 2024, Ms. Harris was granted 11,939 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
  • [F2]This balance includes 548 shares that were acquired pursuant to NeoGenomics' Employee Stock Purchase Plan. The shares were acquired in transactions exempt from Section 16b-3.
  • [F3]Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.
  • [F4]This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 20, 2025 and multiplied by 110%.
  • [F5]On February 21, 2025, Ms. Harris was granted 143,266 stock options. These options vest ratably over the first three anniversary dates of the grant date.
  • [F6]On February 21, 2025, Ms. Harris was granted 84,317 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
  • [F7]Once vested, the shares of common stock are not subject to expiration.
  • [F8]On February 23, 2024, Ms. Harris was granted 25,329 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
  • [F9]On January 1, 2023, Ms. Harris was granted 201,613 stock options. These options vest ratably over the first four anniversary dates of the grant date.

Documents

1 file

Issuer

NEOGENOMICS INC

CIK 0001077183

→
Entity typeother

Related Parties

1
  • filerCIK 0001880847

Filing Metadata

Form type
4
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 4:40 PM ET
Size
29.3 KB
View on SEC.gov